Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07582042 · ClinicalTrials.gov registry record
Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).
A clinical trial, sponsored by University of Utah.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07582042 is a clinical trial that is actively recruiting participants, run by University of Utah. The registered enrollment target is 50 participants.
The verdict
NCT07582042 is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The goal of this observational study is to evaluate changes in retinal sensitivity over time in patients with geographic atrophy due to age related macular degeneration who are receiving pegcetacoplan as part of routine clinical care. The study aims to determine whether lesion tailored fundus-controlled perimetry can reliably measure functional changes near areas of atrophy and whether this testing can be implemented in everyday clinic care over 24 months. Participants will undergo repeated vision testing, standard eye imaging, and visual function questionnaires while continuing their prescribed treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2029-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07582042
The ClinicalTrials.gov registry entry for NCT07582042 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07582042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07582042 about?
NCT07582042 is a clinical study titled "Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).". The goal of this observational study is to evaluate changes in retinal sensitivity over time in patients with geographic atrophy due to age related macular degeneration who are receiving pegcetacoplan as part of routine clinical care. The study aims to determine whether lesion tailored fundus-contro...
What is the current status of trial NCT07582042?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-06-15. Estimated completion is 2029-08-01.
Who is sponsoring clinical trial NCT07582042?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.